He does come across well. Finally someone with actual industry knowledge.
Ebert was hopeless and had no idea but I don't think he was allowed to communicate either. The initial period after listing was positive and the doctor wasn't going to share the limelight with anyone. Once things went south there was just no communication. My take is the new CEO has demanded the opportunity to do it his way and with the performance the Board had no choice but to back him in.
- Forums
- ASX - By Stock
- BFC
- Ann: Appendix 4D and FY2019 Half Year Financial Statements
Ann: Appendix 4D and FY2019 Half Year Financial Statements, page-19
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BFC (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $5.991M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
BFC (ASX) Chart |
Day chart unavailable
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online